Internal Medicine, Interventional Cardiology · Oklahoma City, OK
NPI
1578550505
Since 2005
Specialty
Internal Medicine, Interventional Cardiology
Code 207RI0011X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
4050 W Memorial Rd Fl 3
Oklahoma City, OK, 73120
Phone (405) 608-3800
Groups this clinician bills Medicare through
Medicare paid, 2024
$314K
5,316 services
Medicare patients, 2024
1,560
Average age 77
Drug cost, 2024
$2.7M
14,243 prescriptions
Company payments, 2025
$750
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael A Scherlag was code 99214 (office e&m - established), 1,408 times for 903 patients. In total Michael A Scherlag billed 5,316 services in 78 codes, and Medicare paid $314K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-06-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 1,408 | 903 | $63.94 | $90K |
| 99214 Office E&M - Established | Office | 586 | 389 | $83.09 | $49K |
| 93010 Electrocardiogram | Facility | 568 | 556 | $5.26 | $2,990 |
| 93306 Echocardiography (TTE/TEE) | Facility | 535 | 511 | $44.72 | $24K |
| 93298 External Electrocardiographic Monitoring | Facility | 261 | 36 | $17.03 | $4,445 |
| 93000 Electrocardiogram | Office | 258 | 252 | $8.88 | $2,291 |
| 99152 Anesthesia | Facility | 230 | 193 | $8.84 | $2,034 |
| 93306 Echocardiography (TTE/TEE) | Office | 228 | 226 | $75.54 | $17K |
| 93458 Percutaneous Transcatheterization | Facility | 159 | 155 | $190.02 | $30K |
| 99213 Office E&M - Established | Facility | 116 | 114 | $43.48 | $5,044 |
| 99204 Office E&M - New | Facility | 107 | 107 | $91.65 | $9,806 |
| 93244 Electrocardiogram | Facility | 105 | 96 | $16.03 | $1,683 |
| 93880 Duplex Scan - Extracranial Arteries | Office | 60 | 56 | $64.80 | $3,888 |
| 99232 Hospital E&M - Subsequent | Facility | 56 | 33 | $57.75 | $3,234 |
| 99239 Hospital Discharge Management | Facility | 53 | 48 | $81.94 | $4,343 |
By year: 2022 $301K for 5,066 services; 2023 $315K for 5,166 services; 2024 $314K for 5,316 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael A Scherlag prescribed most often to Medicare patients was Metoprolol Succinate, with 1,291 prescriptions and refills. In total Michael A Scherlag wrote 14,243 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 1,291 | 3,635 | 389 | $21K |
| Losartan Potassium Generic | 1,266 | 3,555 | 363 | $16K |
| Atorvastatin Calcium Generic | 1,252 | 3,568 | 382 | $21K |
| Amlodipine Besylate Generic | 1,085 | 3,038 | 333 | $9,927 |
| Eliquis Apixaban | 1,027 | 2,128 | 246 | $1.2M |
| Carvedilol Generic | 855 | 2,453 | 250 | $11K |
| Diltiazem 24hr Er (Cd) Diltiazem Hcl | 533 | 1,487 | 168 | $14K |
| Spironolactone Generic | 460 | 1,317 | 161 | $4,456 |
| Lisinopril Generic | 457 | 1,346 | 146 | $3,984 |
| Clopidogrel Clopidogrel Bisulfate | 421 | 1,148 | 144 | $5,870 |
| Ezetimibe Generic | 388 | 1,122 | 115 | $14K |
| Jardiance Empagliflozin | 345 | 773 | 99 | $426K |
| Simvastatin Generic | 313 | 929 | 90 | $4,288 |
| Furosemide Generic | 294 | 810 | 115 | $1,565 |
| Hydrochlorothiazide Generic | 285 | 785 | 90 | $1,157 |
Brand drugs: 2,214 claims; generic drugs: 12,029 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael A Scherlag $750 ($750 in general payments such as food, travel and fees) from 11 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $172.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 4 | $172 |
| Pfizer Inc. PFE | 11 | $168 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $117 |
| Merck Sharp & Dohme LLC MRK | 5 | $97.89 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $56.43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35.59 |
| Amgen Inc. AMGN | 2 | $32.52 |
| Boston Scientific Corporation BSX | 1 | $19.44 |
| Lilly USA, LLC LLY | 1 | $18.21 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $16.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.